GISONDI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 13.419
NA - Nord America 12.813
AS - Asia 9.737
SA - Sud America 1.620
AF - Africa 423
OC - Oceania 77
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 38.096
Nazione #
US - Stati Uniti d'America 12.560
RU - Federazione Russa 5.016
SG - Singapore 4.381
IT - Italia 2.535
CN - Cina 2.174
GB - Regno Unito 2.077
BR - Brasile 1.316
HK - Hong Kong 938
VN - Vietnam 884
DE - Germania 666
IE - Irlanda 654
FR - Francia 637
SE - Svezia 567
FI - Finlandia 505
KR - Corea 336
IN - India 191
UA - Ucraina 140
NL - Olanda 139
TR - Turchia 138
ID - Indonesia 131
ES - Italia 117
CA - Canada 110
AR - Argentina 103
JP - Giappone 95
MX - Messico 93
BD - Bangladesh 84
NG - Nigeria 75
TG - Togo 72
PL - Polonia 69
ZA - Sudafrica 69
AU - Australia 65
AT - Austria 57
BJ - Benin 57
IQ - Iraq 57
EC - Ecuador 55
PK - Pakistan 38
SA - Arabia Saudita 37
CH - Svizzera 35
BE - Belgio 34
CO - Colombia 31
UZ - Uzbekistan 31
MA - Marocco 30
CL - Cile 28
IR - Iran 27
EG - Egitto 26
MY - Malesia 25
PY - Paraguay 24
KE - Kenya 21
VE - Venezuela 20
PH - Filippine 19
TN - Tunisia 19
BO - Bolivia 18
DZ - Algeria 18
KZ - Kazakistan 17
AL - Albania 15
CZ - Repubblica Ceca 15
DK - Danimarca 14
HU - Ungheria 14
IL - Israele 14
PT - Portogallo 14
RO - Romania 14
NP - Nepal 13
HR - Croazia 12
JO - Giordania 12
PE - Perù 12
JM - Giamaica 11
UY - Uruguay 11
LT - Lituania 10
NZ - Nuova Zelanda 10
TH - Thailandia 10
AZ - Azerbaigian 9
BG - Bulgaria 9
ET - Etiopia 9
GR - Grecia 9
DO - Repubblica Dominicana 8
MM - Myanmar 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
GE - Georgia 6
GH - Ghana 6
IS - Islanda 6
OM - Oman 6
AO - Angola 5
EE - Estonia 5
LK - Sri Lanka 5
LV - Lettonia 5
BH - Bahrain 4
BN - Brunei Darussalam 4
CR - Costa Rica 4
GD - Grenada 4
KW - Kuwait 4
LB - Libano 4
NO - Norvegia 4
AM - Armenia 3
CG - Congo 3
CI - Costa d'Avorio 3
EU - Europa 3
HN - Honduras 3
KG - Kirghizistan 3
Totale 38.026
Città #
Singapore 2.243
Ashburn 1.772
Southend 1.591
Moscow 1.570
San Jose 1.377
Dallas 1.323
Chandler 1.055
Jacksonville 955
Hong Kong 919
Dublin 643
Woodbridge 552
Verona 546
Houston 442
Ann Arbor 431
The Dalles 407
Beijing 359
Ho Chi Minh City 323
New York 251
Los Angeles 223
Wilmington 220
Lawrence 215
Princeton 215
Hanoi 202
Milan 188
Helsinki 159
Munich 150
Council Bluffs 144
Rome 140
Jinan 135
Nanjing 133
Redondo Beach 130
Buffalo 126
São Paulo 120
London 112
Shenyang 100
Santa Clara 95
Sindelfingen 93
Jakarta 80
Tianjin 73
Lomé 72
Abuja 68
Chicago 66
Frankfurt am Main 64
Hebei 63
Lappeenranta 62
Tokyo 61
Guangzhou 58
Cotonou 57
Seattle 56
Haikou 55
Bologna 53
Changsha 52
Orem 51
Warsaw 51
Washington 48
Amsterdam 47
Columbus 46
Chennai 45
Hangzhou 44
Madrid 44
Nanchang 44
Redwood City 42
Naples 41
Rio de Janeiro 41
Haiphong 39
Da Nang 38
Zhengzhou 38
Atlanta 37
Johannesburg 37
Phoenix 37
Belo Horizonte 36
Brooklyn 36
Boardman 35
Jiaxing 34
Montreal 33
Vienna 33
Mexico City 32
Nuremberg 32
Brasília 29
Brussels 29
Falls Church 29
Florence 29
Kent 29
Toronto 29
Turin 29
Curitiba 28
Ningbo 28
Stockholm 28
Manchester 27
Redmond 27
Tashkent 27
Genoa 26
Istanbul 26
Shanghai 26
Venice 26
Esslingen am Neckar 25
Baghdad 24
Boston 24
Denver 23
San Francisco 23
Totale 22.231
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 671
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 446
Il ruolo della vitamina D nella dermatite atopica 388
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 363
A systematic review of treatments for pityriasis lichenoides 329
A new instrument for the screening of psoriatic arthritis among psoriatic patients 313
Dietary supplements for lipedema 309
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 210
Advanced Glycation End Products in the Pathogenesis of Psoriasis 200
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 199
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 181
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 181
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 177
Heat urticaria: a revision of published cases with an update on classification and management 174
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 172
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 169
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 169
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 169
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 168
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 166
Polymorphisms, diet and nutrigenomics 165
Acneiform eruption induced by cetuximab 163
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 163
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 161
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 160
Retention rate of systemic drugs in patients with chronic plaque psoriasis 159
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 158
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 158
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 158
Gender perspective in the management of psoriasis 158
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 157
Incidence of respiratory and allergic symptoms in Italian and immigrant children 157
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 157
Impact of the COVID-19 pandemic on melanoma diagnosis 156
Psoriasis, the liver, and the gastrointestinal tract 155
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 155
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 155
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer 154
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 150
Lebbra lepromatosa. 150
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 150
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 150
Psoriasis and the metabolic syndrome 149
Squamous cell carcinoma arising in lupus vulgaris. 147
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 147
Impact of TNF-α antagonists on the quality of life in selected skin diseases 147
Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series. 147
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 146
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 146
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 145
Complicanze dell'obesità: la cute 145
Aggiornamento sulla terapie biologiche della psoriasi 144
Targeting TNF-a in psoriasis and psoriatic arthritis. 144
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 144
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature 144
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 143
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis 143
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 143
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 143
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 142
Attitude to treatment of patients with psoriasis attending SPA center 141
Vitamin D levels in patients with psoriasis with or without arthritis 141
Severe impairment of quality of life in Hailey-Hailey disease. 140
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 140
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 138
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 138
Image Gallery: Pyoderma gangrenosum of the penis. 138
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 137
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 137
Pimecrolimus in dermatology: atopic dermatitis and beyond. 135
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 135
Advanced Glycation End Products and Psoriasis 134
Chronic plaque psoriasis is associated with increased arterial stiffness 133
The metabolic syndrome in psoriasis 133
Vitamin D status in patients with chronic plaque psoriasis 132
Considerations for Systemic Treatment of Psoriasis in Obese Patients 132
Effects of secukinumab on serum adipocytokines: preliminary data 132
Diabetes and the Skin 132
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 132
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 131
Psoriasi. Una guida per una migliore gestione del paziente. 131
The expectations of patients with psoriasis during an office consultation 131
Ki67/MART1 and p63/SOX10 Dual Immunohistochemistry Allows a Correct Interpretation of the Melanocytic Component in the Diagnosis of Pigmented Pilomatricoma 131
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 130
Systemic therapy of psoriasis in diabetic patients 130
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 129
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 128
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 127
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 127
Some considerations about the importance of alliance between patients and dermatologists in psoriasis 127
Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam Study 127
Hyperuricaemia in patients with chronic plaque psoriasis. 127
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 126
Phenotypes of atopic dermatitis 126
Metabolic comorbidities and psoriasis. 126
Targeting tumor necrosis factor a in the therapy of psoriasis. 126
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. 125
Patients with psoriasis have a higher prevalence of parental cardiovascular disease 125
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis 125
Dermatite atopica. 124
Totale 16.471
Categoria #
all - tutte 131.529
article - articoli 127.529
book - libri 406
conference - conferenze 0
curatela - curatele 0
other - altro 130
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.464
Totale 263.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 0 0 0 0 27 184 62
2021/20221.439 86 230 38 121 88 91 54 109 79 55 125 363
2022/20233.858 269 238 357 605 270 889 66 195 503 213 181 72
2023/20242.533 119 197 240 281 261 403 149 157 35 110 342 239
2024/20256.581 386 349 230 1.037 360 299 414 308 941 466 582 1.209
2025/202617.462 1.418 925 1.662 2.672 4.371 1.123 1.780 1.209 1.392 910 0 0
Totale 38.517